All Stories

  1. Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock
  2. Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study
  3. Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
  4. The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review
  5. Advances and Challenges in Sepsis Management: Modern Tools and Future Directions
  6. The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
  7. Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
  8. Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
  9. Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature
  10. Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
  11. Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study
  12. Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
  13. Communication and visiting policies in Italian intensive care units during the first COVID-19 pandemic wave and lockdown: a nationwide survey
  14. Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia
  15. Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19
  16. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
  17. Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study
  18. Risk Factors for Pulmonary Air Leak and Clinical Prognosis in Patients With COVID-19 Related Acute Respiratory Failure: A Retrospective Matched Control Study
  19. Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure
  20. Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
  21. Editorial: Putting the Spotlight on the Role of Oxygen in Critically-Ill Patients: From Basic Mechanisms to Clinical Effects
  22. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
  23. Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  24. First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
  25. The effect of non-invasive ventilation on intra-abdominal pressure
  26. Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
  27. Metabolic reprograming shapes neutrophil functions in severe COVID‐19
  28. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
  29. Development of post-COVID-19 cardiovascular events: an analysis of clinical features and risk factors from a single hospital retrospective study
  30. Mapping the human genetic architecture of COVID-19: an update
  31. Acquisition of skills in critical emergency medicine: an experimental study on the SIAARTI Academy CREM experience
  32. Revisited Hyperoxia Pathophysiology in the Perioperative Setting: A Narrative Review
  33. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
  34. Vertebral artery dissection in term pregnancy after cervical spine manipulation: a case report and review the literature
  35. Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
  36. Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia
  37. Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study
  38. Synergistic Effect of Static Compliance and D-dimers to Predict Outcome of Patients with COVID-19-ARDS: A Prospective Multicenter Study
  39. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
  40. A pandemic recap: lessons we have learned
  41. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
  42. Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
  43. A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit
  44. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
  45. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus
  46. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
  47. Hospital-Acquired Infections in Critically Ill Patients With COVID-19
  48. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
  49. Mapping the human genetic architecture of COVID-19
  50. One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19
  51. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19
  52. C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age
  53. Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
  54. Acid base disorders in patients with COVID-19
  55. Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus
  56. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
  57. SELP Asp603Asn and severe thrombosis in COVID-19 males: implication for anti P-selectin monoclonal antibodies treatment
  58. Mergers and acquisitions in emerging markets: What drives absorptive capacity in target firms?
  59. Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
  60. Never Give Up: Lesson learned from a severe COVID-19 patient
  61. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients
  62. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety
  63. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
  64. The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males
  65. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
  66. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
  67. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
  68. Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
  69. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study
  70. Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial)
  71. Post-Mendelian genetic model in COVID-19
  72. Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research
  73. Hypokalemia in Patients with COVID-19
  74. Cluster analysis identifies patients at risk of catheter-associated urinary tract infections in intensive care units: findings from the SPIN-UTI Network
  75. Genetic mechanisms of critical illness in Covid-19
  76. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
  77. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males
  78. Clinical and molecular characterization of COVID-19 hospitalized patients
  79. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
  80. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in males
  81. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
  82. Testicular pain as an unusual presentation of COVID-19: a brief review of SARS-CoV-2 and the testis
  83. Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy
  84. Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis
  85. Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study
  86. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion
  87. The predictive value of fruit juice in the esophagus-pleural fistula
  88. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies
  89. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised c...
  90. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study
  91. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID‐19 patients with pneumonia
  92. Tocilizumab in patients with severe COVID-19: a retrospective cohort study
  93. Employing a Systematic Approach to Biobanking and Analyzing Clinical and Genetic Data for Advancing COVID-19 Research
  94. Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases
  95. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
  96. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
  97. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
  98. Incidence, Risk Factors and Mortality Outcome in Patients with Acute Kidney Injury in COVID-19: A Single-Center Observational Study
  99. A case of splenic artery pseudoaneurysm rupture in a bulimic patient with gastric ulcer
  100. Reply to “Indications and timing for tracheostomy in patients with SARS CoV2‐related” by Ferri et al.
  101. Hypokalemia in Patients with COVID-19
  102. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
  103. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency
  104. Clinical and molecular characterization of COVID-19 hospitalized patients
  105. Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria
  106. The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database
  107. Tracheostomy in the COVID-19 pandemic
  108. Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
  109. Handling and Processing of Blood Specimens from Patients with COVID‐19 for Safe Studies on Cell Phenotype and Cytokine Storm
  110. SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health
  111. Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging
  112. Shorter Androgen Receptor PolyQ Alleles Protect Against Life-Threatening COVID-19 Disease in Males
  113. OUP accepted manuscript
  114. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
  115. Current gaps in sepsis immunology: new opportunities for translational research
  116. University of Modena Experience With Liver Grafts From Donation After Circulatory Death: What Really Matters in Organ Selection?
  117. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
  118. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
  119. What’s new in oxygen therapy?
  120. Oxygen: a powerful drug to handle with care
  121. Cytoreductive surgery and HIPEC in a 14 years old patient with peritoneal recurrence of adenocarcinoma of the right colon
  122. Use of Levosimendan in Intensive Care Unit Settings
  123. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
  124. JLB: a new long-cannula venous catheter
  125. Purpura Fulminans and Septic Shock due to Capnocytophaga Canimorsus after Dog Bite: A Case Report and Review of the Literature
  126. Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro
  127. Experienced Use of Dexmedetomidine in the Intensive Care Unit: A Report of a Structured Consensus
  128. Prognostic Potential of the Panfungal Marker (1 → 3)-β-d-Glucan in Invasive Mycoses Patients
  129. Procalcitonin-guided antibiotic therapy: an expert consensus
  130. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
  131. Oxygen in the critically ill
  132. The prognostic importance of chronic end-stage diseases in geriatric patients admitted to 163 Italian ICUs
  133. Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study
  134. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway
  135. Common Practice and Guidelines for Sedation in Critically Ill Patients
  136. Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia
  137. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference
  138. Effects of short-term hyperoxia on erythropoietin levels and microcirculation in critically Ill patients: a prospective observational pilot study
  139. Injury-induced immunosuppression: are we finally on the right track?
  140. Oxygen Supplementation Among Patients in the Intensive Care Unit
  141. Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria
  142. Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey
  143. The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
  144. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit
  145. Dexmedetomidine for agitated delirium in intensive care unit intubated patients
  146. Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors
  147. A one-year prospective study of refractory status epilepticus in Modena, Italy
  148. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)
  149. A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report
  150. Effect of Performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A Systematic Review and Meta-Analysis of Observational Studies
  151. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis
  152. Trends in ventilator-associated pneumonia: Impact of a ventilator care bundle in an Italian tertiary care hospital intensive care unit
  153. World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections
  154. Wernicke’s encephalopathy in a malnourished surgical patient: a difficult diagnosis
  155. Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock
  156. Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay
  157. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
  158. Erratum to: An Italian consensus for invasive candidiasis management (ITALIC)
  159. Loss of Self-Regulation in Interstitial Fluid Dynamics of Septic Patients, and Oedema Development Patterns
  160. Immunoglobulin as Adjunctive Therapy in Sepsis
  161. Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
  162. A Janus role for MerTK in the outcome of septic shock
  163. Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: A pilot observational study
  164. The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome
  165. Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients
  166. Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex
  167. Hemostasis in acute liver and kidney failure: nothing is as it seems
  168. Aggressive versus conservative initiation of antibiotics
  169. Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: a single-center experience
  170. Early alterations of B cells in patients with septic shock: another piece in the complex puzzle of the immune response in sepsis
  171. Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia
  172. Levosimendan in a case of severe peri-myocarditis associated with influenza A/H1N1 virus
  173. Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis
  174. A new technique for percutaneous dilatational tracheostomy (G-Trach): preliminary experience in pigs
  175. Abdominal Compartment Syndrome and Fluid Replacement: A Dog That Bites Its Own Tail?
  176. Erratum
  177. PSP/reg: a new stone in sepsis biomarkers?
  178. Massive bleeding: Are we doing our best?
  179. Acute Renal Failure and Renal Replacement Therapy in the Postoperative Period of Orthotopic Liver Transplant Patients Versus Nonelective Abdominal Surgery Patients
  180. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection
  181. Posttraumatic massive bleeding: a challenging multidisciplinary task
  182. Levosimendan in Cardiac Failure After Subarachnoid Hemorrhage
  183. Two-stage liver transplantation: an effective procedure in urgent conditions
  184. Perioperative Red Blood Cell Transfusion and Outcome in Stable Patients after Elective Major Vascular Surgery
  185. Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study
  186. Use of activated protein c in liver transplantation patients with septic shock
  187. Incidence and Clinical Outcomes of Ventilator-Associated Pneumonia in Liver Transplant and Non-Liver Transplant Surgical Patients
  188. Recombinant Activated Factor VII in Critical Bleeding After Orthotopic Liver Transplantation
  189. Strategies to Control Massive Abdominal Bleeding
  190. A modified goal-directed protocol improves clinical outcome in intensive care unit patients with septic shock patients
  191. Liver transplantation in HIV patients
  192. Peri-operative respiratory failure in a cirrhotic patient: a misleading diagnosis
  193. Gram-Positive Bloodstream Infections in Liver Transplant Recipients: Incidence, Risk Factors, and Impact on Survival
  194. Intracerebral haemorrhage: an often neglected medical emergency
  195. Living Donor Liver Transplantation and Management of Portal Venous Pressure
  196. Intra-abdominal Hypertension in Nonelective Surgery: A Preliminary Report
  197. Posttransplant Cerebral Hemorrhage in a Patient with Familial Amyloidotic Polyneuropathy
  198. Rectal amputation sparing by haemostatic therapy with recombinant factor VIIa in a patient with cytomegalovirus–related colitis
  199. More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation
  200. Comment on: ?Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock? by Formica et al.
  201. Muscle perfusion and oxygen consumption by near-infrared spectroscopy in septic-shock and non-septic-shock patients
  202. Extravascular lung water and intravascular volume monitoring
  203. Pain management after small bowel/multivisceral transplantation
  204. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone
  205. Oxygen cost of dynamic leg exercise on a cycle ergometer: effects of gravity acceleration
  206. Severe hypoxemia and pulmonary hypertension during orthotopic liver transplantation: a successful use of inhaled nitric oxide
  207. Effects of prolonged bed rest on cardiovascular oxygen transport during submaximal exercise in humans
  208. Effects of elastic recoil on maximal explosive power of the lower limbs
  209. The Effect of Laparoscopic Cholecystectomy on Cardiovascular Function and Pulmonary Gas Exchange
  210. The Effect of Laparoscopic Cholecystectomy on Cardiovascular Function and Pulmonary Gas Exchange
  211. Oxygen cost of internal work during cycling
  212. Noninvasive assessment of cardiac output from arterial pressure profiles during exercise
  213. Assessment of cardiac output from noninvasive determination of arterial pressure profile in subjects at rest
  214. Effects of prolonged cycle ergometer exercise on maximal muscle power and oxygen uptake in humans
  215. Severe bleeding in critical care